Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92,189,700
-
Total 13F shares
-
66,748,618
-
Share change
-
-2,315,542
-
Total reported value
-
$342,979,667
-
Put/Call ratio
-
94%
-
Price per share
-
$5.14
-
Number of holders
-
149
-
Value change
-
-$13,445,660
-
Number of buys
-
68
-
Number of sells
-
64
Institutional Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q1 2024
As of 31 Mar 2024,
Caribou Biosciences, Inc. - Common Stock (CRBU) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,748,618 shares.
The largest 10 holders included
BlackRock Inc., PFM Health Sciences, LP, STATE STREET CORP, Avidity Partners Management LP, VANGUARD GROUP INC, Point72 Asset Management, L.P., ALKEON CAPITAL MANAGEMENT LLC, Elmwood Wealth Management, Inc., Paradigm Biocapital Advisors LP, and DIMENSIONAL FUND ADVISORS LP.
This page lists
149
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.